Skip to main content

Advertisement

Table 2 Expected Cost and Effectiveness of Continuous Glucose Monitoring (CGM) and Self-Monitoring of Blood Glucose (SMBG)

From: Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes

Strategy Expected Cost in 2007 $US (range)* Expected Effectiveness QALYs (range)* Incremental cost-effectiveness ratio (ICER)
SMBG 470,583 (397,782 - 550,598) 10.289 (9.615 - 10.957)  
CGM and SMBG 494,135 (420,381 - 571,631) 10.812 (9.894 - 11.887) US $45,033/QALY
  1. *95% credible ranges based on the results from the 10,000 Monte Carlo simulations